Validation of COMPAT-SF Spanish Transla… | Clinical Trial

Key information

Conditions

Chronic Pancreatitis Chronic Disease Digestive System Diseases Disease Attributes Pancreatic Diseases Pancreatitis Pancreatitis, Chronic Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Methodist Dallas Medical Center- Clinical Research Institute

Dallas, Texas, 75203, United States

Location status: Recruiting

About this study

Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years or older in age
Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
Able to read and understand the study information in Spanish
Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study
Subject is willing and able to comply with the scheduled questionnaires

Exclusion criteria

Subjects who do not meet the criteria in section 4.1

Treatment and study plan

Questionnaires

Behavioral

Administer translated COMPAT-SF questionnaires to Spanish-speaking CP patients

Primary outcomes

Face validity:

Time frame: through study completion, up to 18 months

Patient-reported feedback through a questionnaire concerning the feasibility of the translated COMPAT-SF questionnaire

Study contacts

Contact information is provided by the study sponsor or research team.

Jeff Wilson

CONTACT

[email protected]

2149471279

Sponsors and collaborators

Lead sponsor

Methodist Health System

Other

Collaborators

Aalborg University Hospital

Registry information

Important dates

Study start: 2024
Primary completion: 2026
Study completion: 2026
First posted: Nov 20, 2024
Registry last updated: Nov 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting